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Introduction. Obesity is a risk factor to develop metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM). Insulin
resistance (IR) plays a major part in both. With increasing incidence of childhood obesity, this retrospective study aimed to
identify predictors of IR in children/adolescents with obesity to optimize screening for IR. Method. Patients aged≥ 2–≤18 years
with obesity (BMI-SDS> 2.3) were included. IR was de?ned as HOMA-IR≥ 3.4, and MetS if ≥3 of the following criteria were
present: waist circumference and blood pressure≥ 95th age percentile, triglycerides≥ 1.7mmol/l, HDL< 1.03mmol/l, and fasting
plasma glucose≥ 5.6mmol/l. Results. In total, 777 patients were included. Of the 306 children, 51, 38, and 0 were diagnosed with
IR, MetS, and T2DM, respectively. Of the 471 adolescents, 223, 95, and 0 were diagnosed with IR, MetS, and T2DM, respectively.
In the multivariable regression model, BMI-SDS, preterm birth, and Tanner stage were associated with IR in children (6.3 (95% CI
1.3–31.1), 5.4 (95%CI 1.4–20.5), 2.2 (95%CI 1.0–4.8)), and BMI-SDS and waist circumference in adolescents (4.0 (95%CI 1.7–9.2),
3.7 (95%CI 1.5–9.4)).Conclusion. DiCerent IR predictors were observed in children/adolescents with obesity.2ese predictors can
be used to optimize screening for IR in pediatric populations.
1. Introduction
Obesity is a major health problem with an expanding burden
on society, not only due to a rising prevalence in both the
developed and developing world but also because of the onset
at younger age [1–3]. As a consequence, associated compli-
cations such as metabolic syndrome (MetS), type 2 diabetes
mellitus (T2DM), cardiovascular diseases, respiratory ill-
nesses, and psychosocial problems are now more frequently
seen in pediatric populations [4, 5].
Insulin resistance (IR) is associated with obesity due to
lipolytic eCects of adipocytes, leading to large amounts of
free fatty acids and impaired secretion of adipokines, both
involved in the modulation of insulin sensitivity [6, 7]. IR is
usually the ?rst sign of a disturbed glucose metabolism.
In case of IR, insulin production by the pancreatic beta cells
is increased, causing hyperinsulinemia [6, 8, 9]. Failure of
this compensatory response leads to impaired glucose tol-
erance (IGT) and eventually T2DM [8, 10]. Apart from being
a risk factor for T2DM, IR has also been recognized as an
independent risk factor for development of cardiovascular
diseases by potentiating the onset of dyslipidaemia [6, 11].
Moreover, IR is frequently associated with MetS, whose
components are (central) obesity, high blood pressure, high
triglycerides, low HDL, and impaired fasting plasma glucose
(FPG) [8, 12].
2e gold standard to determine IR is the euglycemic-
hyperinsulinemic clamp study. 2is invasive method is not
routinely used in daily clinical practice; instead, surrogate
measures are used. 2e measures diCer in methods and
cutoC values and are used concurrently, causing high var-
iation in reported prevalence rates [13, 14]. 2e Homeostasis
Model for the Assessment of Insulin Resistance (HOMA-IR)
is the most commonly used method in daily practice [14].
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In the pediatric population, IR is commonly seen in
adolescents, as transient insulin resistance occurs during
puberty due to high circulating levels of growth hormone
[8, 15, 16]; however, IR is also observed before puberty [8].
A higher prevalence of IR is seen in adolescents with
obesity irrespective of puberty [17], which implicates a re-
lation between IR and obesity, as described above [6–8].
Recently, IR is increasingly observed in children with
obesity [18, 19]. While this can be a consequence of the rising
prevalence of obesity at younger age, recent studies also
hypothesized other risk factors, such as preterm birth, low
birth weight, absence of breastfeeding, and family history of
diabetes and obesity [4, 18–20].
Identifying predictors of IR in the obese pediatric
population is important as they can be used as a screening
tool for those at risk for complications such as MetS and
T2DM. Furthermore, since diCerent predictors of IR are
supposed in children and adolescents with obesity, it is
important to distinguish between these two age groups.2us
far, studies comparing predictors of IR in children and
adolescents with obesity are limited. 2erefore, the aim of
the current retrospective study is to identify predictors of IR
in a cohort of children and adolescents with obesity, to
optimize screening for IR.
2. Method
2.1. Study Design and Subjects. 2is retrospective cross-
sectional observational study was approved by the Medical
Ethical Committee of the St. Antonius Hospital, Nieuwegein/
Utrecht, the Netherlands (W15.038). Need for written in-
formed consent was waived as only data obtained during
routine clinical care were used and analyzed anonymously.
2is implies that no additional blood samples were taken for
this study. Patients who visited the pediatric outpatient clinic
of the St. Antonius Hospital, between 2006 and 2014, with the
DBC code “adiposity” (“Diagnose Behandeling Combinatie,”
abbreviated to “DBC” in Dutch) were considered. Inclusion
criteria were age≥ 2–≤18 years, obesity (de?ned as BMI-
SDS> 2.3), and available laboratory results on fasting plasma
glucose (FPG) and fasting plasma insulin (FPI). Patients with
weight-aCecting disorders were excluded.
2.2. Measurements. From (electronic) medical records, pa-
tient demographics and anthropometric measurements,
that is, date of birth, gender, ethnicity, term of birth, birth
weight, infant feeding, length, weight, waist circumference,
blood pressure, and stage of puberty, were retrieved. More-
over, laboratory results of blood samples, taken for routine
clinical care, for FPG, FPI, high-density lipoprotein (HDL),
low-density protein (LDL), triglycerides, and total choles-
terol (TC) and family history of obesity, T2DM, dyslipi-
daemia, hypertension, and cardiovascular diseases (CVDs)
were collected.
Participants were classi?ed as children if they were <10
years of age and as adolescents if they were≥ 10 years of age.
Ethnicity was classi?ed as Caucasian or non-Caucasian.
Term of birth was categorized into preterm (gestational
age≤ 37 weeks) and term or postterm (gestational age>
37 weeks). Birth weight was categorized into appropriate for
gestational age (AGA) and small or large for gestational
age (SGA≤ 5th percentile/LGA≥ 95th percentile), using
reference values of the Dutch Perinatal Registry [21].
Infant feeding was divided into breastfeeding, de?ned as
administered for at least 28 days, or formula feeding. All
anthropometric measurements and laboratory results were
obtained from the intake visit to the pediatric outpatient
clinic. Weight and length were measured using a digital
scale (Seca, Hamburg, Germany) with an accuracy of
0.05 kg and a digital stadiometer with a precision of
0.1 cm (DGI 250D, De Grood, Nijmegen, the Netherlands),
respectively. Body mass index (BMI) and BMI standard
deviation score (SDS) were calculated using the TNO
growth calculator for professionals [22]. Waist circum-
ference was measured midway, between the lowest rib
and upper border of the iliac crest at the end of a gentle
expiration, with a precision of 0.1 cm, using an inextensible
tape with millimeter scale while the patient was in standing
position. Waist circumference was categorized in normal
or obese waist, based on Dutch reference values [23].
Stage of puberty was assessed by the attending physician,
using Tanner stage, and categorized into prepubertal (T1),
pubertal (T2–4), and postpubertal (T5). Blood pressure
was measured in supine position from the right arm.
Hypertension was de?ned as systolic and/or diastolic blood
pressure ≥ 95th percentile for age [24].
IR was calculated using Homeostatic Model Assess-
ment for Insulin Resistance (HOMA-IR) (FPG (mmol/L)×
FPI (mU/L)/22.5) [25] and de?ned as HOMA-IR≥ 3.4 [26].
MetS was de?ned as the presence of at least 3 of the fol-
lowing criteria: waist circumference≥ 95th percentile for
age [23], systolic blood pressure and/or diastolic blood
pressure ≥ 95th percentile for age [24], triglycerides ≥
1.7mmol/l, HDL< 1.03mmol/l, and fasting plasma gluco-
se≥ 5.6mmol/l. Family history of obesity, T2DM, dyslipidae-
mia, hypertension, and CVDs were categorized as ?rst degree,
second degree, or no family aCected.
2.3. Statistical Analysis. Statistical analysis was performed
using IBM SPSS Statistics, version 24 (IBM SPSS Statis-
tics, Chicago, IL, USA). Normally distributed continuous
parameters were reported as mean ± standard deviation
and nonparametric continuous parameters as median with
range. Categorical data were expressed as frequencies with
percentage. Student’s t-test was used to compare normal
distributed continuous variables and the Mann–Whitney
U test for nonnormal distributed data. 2e chi-squared
test was used to analyze diCerences in categorical variables
and the one-way ANOVA or Kruskal–Wallis test in non-
parametric data, when comparing more than two groups.
Binary logistic regression was used to investigate the
association between IR and BMI-SDS, Tanner stage, term
of birth, birth weight, breastfeeding, and waist circum-
ference, with adjustment for age, gender, and ethnicity.
An α-level of 5% was considered signi?cant for all sta-
tistical tests.
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3. Results
Figure 1 shows that in total 1173 patients with obesity were
considered for inclusion. For various reasons, 396 patients
were excluded. In total, 777 patients were included, 306
children and 471 adolescents, of which 51 and 223 were
diagnosed with IR, respectively.
Tables 1–3 show the demographics, anthropometric
measurements, and laboratory results, respectively, of the
included children and adolescents, with and without IR.
Both children and adolescents with IR were signi?cantly
older and taller and had a higher weight and higher BMI-
SDS (Tables 1 and 2). In addition, both children and ado-
lescents had signi?cantly higher triglycerides and lower
HDL (Table 3). MetS was diagnosed signi?cantly more in
children and adolescents with IR, while none of the par-
ticipants was diagnosed with T2DM (Table 2). Children with
IR were primarily girls (P  0.035); in addition, signi?cantly
more preterm birth and higher Tanner stages were observed
in the IR group (Tables 1 and 2). No diCerences were ob-
served in blood pressure, waist circumference, and family
history. In adolescents with IR, an obese waist circumference
was signi?cantly more often observed (Table 2). 2ey also
had signi?cantly more family members with dyslipidemia
((?rst degree 32 (15.2%) versus 22 (10.3%), second degree (60
(28.4%) versus 42 (19.7%)), P  0.015)). Furthermore, sys-
tolic blood pressure was signi?cantly higher (Table 2). No
diCerences were found in family history of T2DM, obesity,
hypertension, and CVDs.
2e multivariate logistic regression model showed that
term of birth, Tanner stage, and BMI-SDS were associated
with IR development in children. In adolescents, BMI-SDS
and waist circumference were associated with IR (Table 4).
4. Discussion
Obesity is increasingly prevalent at younger age and so are
related complications such as MetS and T2DM [1–3]. Since
IR is associated with obesity and a known risk factor for
MetS and T2DM, recognizing the predictors of IR is crucial
for optimal screening. DiCerent predictors of IR in children
and adolescents with obesity were observed. BMI-SDS was
associated with IR in children and adolescents. Furthermore,
preterm birth and Tanner stage were associated with IR in
children, and waist circumference was associated with IR in
adolescents.
InPuence of puberty on IR development is amuch debated
topic. Cross-sectional studies have shown that the prevalence
No IR
n = 238
IR
n = 233
No IR
n = 255
IR
n = 51
Excluded n = 396
 (i) Double and/or misclassified registration n = 269
 (ii) Not meeting inclusion criteria n = 118
(iii) Meeting exclusion criteria n = 9
DBC code “adiposity”
n = 1173
Eligible for inclusion
n = 777
Adolescents
n = 471
Children
n = 306
Figure 1: Flowchart of the study population.
Table 1: Demographics of obese children and adolescents, strati?ed by IR.
Children n 306 Adolescents n 471
IR n 51 No IR n 255 P value IR n 233 No IR n 238 P value
Age (yr) 8.1 (3.9–9.9) 7.3 (2.4–9.9) 0.003 13.2 (10.0–17.9) 12.3 (10.0–17.8) 0.001
Male n (%) 16 (31.4) 121 (47.5) 0.035 115 (49.4) 126 (52.9) 0.436
Caucasian n (%) 35 (68.6) 167 (65.5) 0.829 157 (67.4) 137 (57.6) 0.128
Preterm birth n (%) 8 (15.6) 16 (6.3) 0.027 21 (9.0) 13 (5.5) 0.224
SGA/LGA n (%) 8 (15.6) 34 (13.3) 0.708 38 (16.3) 46 (19.3) 0.141
Breastfeeding n (%) 17 (33.3) 77 (30.2) 0.709 83 (35.6) 75 (31.5) 0.170
Data presented as number (%), mean (standard deviation), or median with range. SGA/LGA small for gestational age/large for gestational age. P values for
unpaired t-test (normally distributed data), Mann–Whitney U test (nonparametric data), and χ2 tests (categorical data). P values in bold are signi?cant at <0.05.
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of IR is increasing at start of puberty, peaks at Tanner stage 3,
and returns to prepubertal levels by the end of puberty, re-
gardless of the presence of obesity [10, 15, 16]. It is known that
transient physiological IR induces extra stress on pancreatic
beta cells, whichmakes puberty a risky period forMetS and/or
T2DM development, especially in those with obesity [10].
In the current study, an association between IR and
Tanner stage was only observed in children. 2is suggests
that IR in children is inPuenced by puberty in contrast to
adolescents. In addition, early onset of puberty is associated
with increased cardiometabolic risk, at least in girls [27].
2is emphasizes that screening on IR in children with early
Table 2: Anthropometric measurements of obese children and adolescents, strati?ed by IR.
Children n 306 Adolescents n 471
IR n 51 No IR n 255 P value IR n233 No IR n 238 P value
Length (cm) 134.1 (10.9) 128.3 (13.6) 0.004 162.2 (10.5) 158.5 (11.9) <0.001
Length-SDS 0.64 (1.04) 0.47 (0.99) 0.280 0.16 (1.05) 0.10 (1.09) 0.569
Weight (kg) 47.9 (11.6) 40.2 (10.7) <0.001 85.2 (20.5) 75.2 (17.9) <0.001
BMI (kg/m2) 26.3 (3.2) 24.1 (2.7) <0.001 31.9 (5.0) 29.4 (3.8) <0.001
BMI-SDS 3.70 (0.69) 3.41 (0.77) 0.015 3.24 (0.47) 3.01 (0.46) <0.001
Obese waist n (%) 29 (56.9) 141 (55.2) 0.557 144 (61.8) 124 (52.1) 0.002
High SBP n (%) 23 (45.1) 92 (36.0) 0.193 102 (43.8) 76 (31.9) 0.022
High DBP n (%) 6 (11.8) 34 (13.3) 0.759 21 (9.0) 17 (7.1) 0.555
Tanner stage n (%) — — <0.001 — — 0.550
(i) Prepubertal (T1) 38 (74.5) 232 (90.9) — 37 (15.9) 46 (19.3) —
(ii) Pubertal (T2–4) 11(21.6) 12 (4.7) — 108 (45.4) 102 (42.9) —
(iii) Postpubertal (T5) — — — 39 (16.7) 37 (15.5) —
MetS n (%) 13 (25.5) 25 (9.8) 0.002 71 (30.5) 24 (10.1) <0.001
T2DM n (%) — — — — — —
Data presented as number (%), mean (standard deviation), or median with range. BMI body mass index, SDS standard deviation score, SBP systolic
blood pressure, DBP diastolic blood pressure, MetSmetabolic syndrome, T2DM type II diabetes mellitus. P values for unpaired t-test (normally
distributed data), Mann–Whitney U test (nonparametric data), and χ2 tests (categorical data). P values in bold are signi?cant at <0.05.
Table 3: Laboratory results of obese children and adolescents, strati?ed by IR.
Children n 306 Adolescents n 471
IR n 51 No IR n 255 P value IR n 233 No IR n 238 P value
FPG (mmol/L) 5.1 (0.5) 4.9 (0.4) <0.001 5.2 (0.5) 5.0 (0.4) <0.001
FPI (mU/L) 19.5 (11.0–50.2) 5.4 (1.0–16.0) <0.001 24.0 (13.9–69.0) 9.0 (1.1–15.7) <0.001
HOMA-IR 4.38 (3.4–13.4) 1.16 (0.2–3.3) <0.001 4.85 (3.4–19.9) 1.99 (0.3–3.3) <0.001
TC (mmol/l) 4.30 (0.73) 4.32 (0.74) 0.716 4.3 (0.85) 4.3 (0.77) 0.949
HDL (mmol/l) 1.2 (0.34) 1.3 (0.30) 0.039 1.15 (0.26) 1.27 (0.29) <0.001
LDL (mmol/l) 2.6 (0.71) 2.49 (0.62) 0.291 2.6 (0.75) 2.5 (0.69) 0.525
TG (mmol/l) 1.4 (0.46) 0.9 (0.63) <0.001 1.29 (0.66) 1.04 (0.54) <0.001
Data presented mean (standard deviation) or median with range. FPG fasting plasma glucose, FPI fasting plasma insulin, HOMA-IR homeostatic
assessment for IR, IR  insulin resistance, TC  total cholesterol, TG  triglycerides. P values for unpaired t-test (normally distributed data) and
Mann–Whitney U test (nonparametric data). P values in bold are signi?cant at <0.05.
Table 4: Adjusted∗ RRs and 95% CI between BMI-SDS, Tanner stage, term of birth, birth weight, breastfeeding, and waist circumference
(independent variables) and IR (dependent variable).
Children Adolescents
RR (95% CI) P value RR (95% CI) P value
BMI-SDS 2.19 (1.01–4.76) 0.048 3.96 (1.70–9.21) 0.001
Tanner stage 5.43 (1.44–20.45) 0.012 1.70 (0.85–3.41) 0.137
Term of birth 6.29 (1.27–31.05) 0.024 2.64 (0.54–12.83) 0.230
Birth weight 1.66 (0.36–7.61) 0.513 0.49 (0.21–1.13) 0.093
Breastfeeding 1.72 (0.61–4.86) 0.309 1.58 (0.76–3.29) 0.222
Waist circumference 1.15 (0.30–4.37) 0.840 3.743 (1.49–9.36) 0.005∗Adjustment for age, gender, and ethnicity. P values in bold are signi?cant at <0.05.
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onset of puberty is essential. An explanation for the observed
diCerence in the association with puberty in children and
adolescents could be the degree of obesity in the adolescent
population, as obesity contributes to IR development [6, 7,
16, 28]. In the current study, the degree of obesity, especially
the waist circumference as measure of fat distribution in the
adolescent population, may blur the association with pu-
berty. 2is may explain why Tanner stage is not a predictor
of IR in adolescents, and therefore, screening during puberty
in adolescents is warranted.
2e importance of waist circumference in de?ning
obesity instead of BMI-SDS is also emphasized in recent
literature [8, 23, 29, 30]. In the studied population, only in
adolescents, waist circumference was associated with IR.
2is stresses the importance of measuring waist circum-
ference during routine clinical care. Why waist circumfer-
ence is not associated with IR in children could be the eCect
of the diCerent fat distribution [16, 28]. Goran et al. assumed
that lack of major eCects of abdominal fat mass on insulin
sensitivity in young children may be explained by relatively
lower levels of subcutaneous abdominal fat [15]. Based on
our data, waist circumference might not be the preferable
method to de?ne obesity in children as discussed in recent
literature.2erefore, in children, BMI-SDS should be used to
de?ne obesity.
2e observation that IR was associated with preterm
birth, supported by studies describing a relationship between
preterm birth and altered insulin homeostasis, is demon-
strated by an increased risk of IR in childhood and young
adulthood [18, 31–33]. Special attention for IR during
long-term follow-up of preterm-born children is therefore
recommended. In adolescents no signi?cant association
between IR and preterm brith was observed, although a
trend was shown. Possibly other factors may have a greater
inPuence, or missing data inPuenced the results.
In children, girls were signi?cantly more diagnosed
with IR. 2is is in concordance with recent literature; in
addition, a higher prevalence of IR in girls without obesity
is described [13]. 2is result can be explained by the fact
that pubertal development starts earlier in girls. In ado-
lescents, no diCerence in gender was observed, possibly
because the degree of obesity blurred the eCect of puberty
as described earlier.
Obesity is a well-known risk factor for MetS and T2DM
[12]. MetS was frequently diagnosed in children and ado-
lescents with IR. T2DMwas not yet diagnosed in the studied
population; however, many participants already had an IGT.
2ese observations are worrisome, since it is known that
children and adolescents with obesity have a risk up to 70%
to remain obese in adulthood [34]. Abdominal fat is asso-
ciated with a higher systolic blood pressure [35]. 2e high
systolic blood pressure observed in adolescents with IR
is probably inPuenced by the level of subcutaneous fat mass,
as an obese waist circumference was more frequently
measured in the adolescents with IR. 2is might explain as
well, why in children this diCerence was not observed.
Higher triglyceride and lower HDL levels were observed in
children and adolescents with IR. 2e association with IR
and alterations in lipid pro?le is in line with the literature,
although no discrepancy was made between children and
adolescents [30, 34]. Based on the association with IR, the
suggestion to incorporate triglycerides in the de?nition of IR
is done [36, 37]; however, added value has not yet been
proven [13].
2is study examined systematically the predictors of IR
in a large cohort of children and adolescents with obesity in
the Netherlands. We focused on BMI-SDS and other
known risk factors for development of IR. However, certain
limitations due to the retrospective cross-sectional obser-
vational study design must be considered. Firstly, the
intraindividual variation in the measurement of plasma
insulin has to be mentioned. 2e intraindividual variation
is caused by the pulsatile excretion of insulin which is
inPuenced by the time of the blood sample and the con-
dition of the patient, especially stressed and/or active.
Variation up to 12% in the plasma insulin concentration
and consequently in the HOMA-IR has been described [26,
38]. 2erefore, to minimize this, intraindividual variation
in insulin measurements should be performed twice under
standardised circumstances. All fasted blood samples were
taken at the pediatric day clinic, early morning by vena
puncture after an overnight fasting period. Although in-
sulin measurements have been performed, according to the
hospital protocol, intraindividual variation might have
inPuenced the prevalence of IR.
Secondly, the uniform cutoC value of the HOMA-IR to
diagnose IR in the entire study population might have
inPuenced the prevalence of IR. Since the used cutoC value
was based on themean value for 95th percentile in two studies
in normal weight children with a similar age range, we think
that the uniform cutoC value for HOMA-IR was justi?ed [26,
39, 40]. Finally, consequently to retrospective studies, in-
complete data exist. In the current study, incomplete data
were observed on medical history (e.g., pregnancy, neonatal,
and weight gain in the ?rst year of life) and sedentary life
style.2e incomplete datamight have had some impact on the
study results. 2erefore in prospective studies, data on
medical history and sedentary life style are obligatory to study
the impact on the risk factors of IR in children and adoles-
cents with obesity.
5. Conclusions
In the current study, diCerent predictors of IR were observed
in children and adolescents. BMI-SDS was associated with
IR in children and adolescents, preterm birth and Tanner
stage were associated with IR in children, and waist cir-
cumference was associated with IR in adolescents. 2ese
predictors can be used to optimize screening for IR in pe-
diatric populations. In future prospective studies, the impact
of medical history and sedentary life style on the risk factors
of IR in children and adolescents with obesity should be
studied.
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